Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects.
Rupprecht R, Rammes G, Eser D, Baghai TC, Schüle C, Nothdurfter C, Troxler T, Gentsch C, Kalkman HO, Chaperon F, Uzunov V, McAllister KH, Bertaina-Anglade V, La Rochelle CD, Tuerck D, Floesser A, Kiese B, Schumacher M, Landgraf R, Holsboer F, Kucher K. Rupprecht R, et al. Among authors: la rochelle cd. Science. 2009 Jul 24;325(5939):490-3. doi: 10.1126/science.1175055. Epub 2009 Jun 18. Science. 2009. PMID: 19541954 Clinical Trial.
Correction: Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study.
Loiodice S, Drinkenburg WH, Ahnaou A, McCarthy A, Viardot G, Cayre E, Rion B, Bertaina-Anglade V, Mano M, L'Hostis P, La Rochelle CD, Kas MJ, Danjou P. Loiodice S, et al. Among authors: la rochelle cd. Transl Psychiatry. 2021 May 10;11(1):276. doi: 10.1038/s41398-021-01408-5. Transl Psychiatry. 2021. PMID: 33972502 Free PMC article. No abstract available.
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
Millan MJ, Brocco M, Papp M, Serres F, La Rochelle CD, Sharp T, Peglion JL, Dekeyne A. Millan MJ, et al. Among authors: la rochelle cd. J Pharmacol Exp Ther. 2004 Jun;309(3):936-50. doi: 10.1124/jpet.103.062463. Epub 2004 Feb 20. J Pharmacol Exp Ther. 2004. PMID: 14978196 Free article.
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology.
Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang JM, Ganellin CR, Stark H, Schunack W, Schwartz JC. Ligneau X, et al. Among authors: la rochelle cd. J Pharmacol Exp Ther. 2007 Jan;320(1):365-75. doi: 10.1124/jpet.106.111039. Epub 2006 Sep 27. J Pharmacol Exp Ther. 2007. PMID: 17005916
Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist.
O'Connor SE, Grosset A, La Rochelle CD, Gautier E, Bidouard JP, Robineau P, Caille D, Janiak P. O'Connor SE, et al. Among authors: la rochelle cd. Eur J Pharmacol. 2001 Mar 2;414(2-3):259-69. doi: 10.1016/s0014-2999(01)00804-4. Eur J Pharmacol. 2001. PMID: 11239927
[No title available]
[No authors listed] [No authors listed] PMID: 31962958
17 results